Company record
Mark J. Savant, M.D
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Mark J. Savant, M.D.
Warning letters
-
DrugsMark J. Savant, M.D
FDA warns clinical investigator Mark J. Savant, M.D., over protocol dosing and eligibility failures and missing informed consent in a drug trial.
High risk